NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/10/2022
Voltar para busca
Dado oficial do USPTO
CORVAL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
42
Atualização mais recente
04/10/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 42
Data de depósito
20/12/2019
Data de registro
04/10/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
04/10/2022
Última transação
04/10/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
24/06/2022
Primeiro uso no comércio
24/06/2022
Código do desenho
4
Tipo de titular
16
Localização do titular
Waban, MA, US
Examinador
STEIN, JAMES W
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Corval LLC
Representantes
EMILY C TSENG DANIELSON LEGAL LLC
Classificação técnica
Classes Nice
Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Consulting services in the fields of life sciences and biotechnologyproviding business planning and strategy services to manufacturers relating to the commercialization of new pharmaceutical drugsbiopharmaceuticalstherapeutics for the treatment of disease; Consulting services in the fields of life sciences and biotechnologyproviding strategic roadmaps to manufacturers to inform business planningidentify objectives and track activities relating to the commercialization of new pharmaceutical drugsbiopharmaceuticalstherapeutics for the treatment of disease
Classe 42
Providing software as a service (SaaS)non-downloadable web-based software for use by manufacturers in the fields of life sciences and pharmaceuticals for facilitating and streamlining the commercialization of new pharmaceutical drugsbiopharmaceuticalstherapeutics for the treatment of disease; Providing collaborative planning and technology solutions to manufacturers in the fields of life sciences and pharmaceuticalsproviding web-based software for cloud-based collaboration and strategic planning relating to the commercialization of new pharmaceutical drugsbiopharmaceuticalstherapeutics for the treatment of disease; Development and implementation of collaborative planning and technology solutions for use by manufacturers in the fields of life sciences and pharmaceuticalsdevelopment and implementation of web-based software that enables users to connect and collaborate with each other to plan business and market entry strategies relating to the commercialization of new pharmaceutical drugsbiopharmaceuticalstherapeutics for the treatment of disease
Publicações
Histórico de despachos e eventos da marca no USPTO.
42 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
04/10/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
27/08/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
26/08/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
20/07/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
20/07/2022
IUAF
USE AMENDMENT FILED
01/07/2022
EISU
TEAS STATEMENT OF USE RECEIVED
01/07/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/01/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/11/2021
PUBO
PUBLISHED FOR OPPOSITION
09/11/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/10/2021
EXPT
EXPARTE APPEAL TERMINATED
01/10/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/10/2021
GEA1
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
14/09/2021
GECD
ACTION DENYING REQ FOR RECON E-MAILED
14/09/2021
CNCF
ACTION CONTINUING FINAL - COMPLETED
14/09/2021
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
05/08/2021
GEA1
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
25/05/2021
GECD
ACTION DENYING REQ FOR RECON E-MAILED
25/05/2021
CNCF
ACTION CONTINUING FINAL - COMPLETED
25/05/2021
EXPI
EX PARTE APPEAL-INSTITUTED
26/04/2021
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
26/04/2021
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
26/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/04/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/04/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/04/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/03/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/03/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/03/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
26/10/2020
GNFR
FINAL REFUSAL E-MAILED
26/10/2020
CNFR
FINAL REFUSAL WRITTEN
26/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/09/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/09/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
19/03/2020
GNRT
NON-FINAL ACTION E-MAILED
19/03/2020
CNRT
NON-FINAL ACTION WRITTEN
19/03/2020
DOCK
ASSIGNED TO EXAMINER
19/03/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/12/2019
NWAP
NEW APPLICATION ENTERED
24/12/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CORVAL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.